Amyloid cross-interactions: how proteins influence each other’s aggregation 🧬🧊

amyloids
publications
A comprehensive review of experimental methods to study amyloid cross-interactions, highlighting how proteins modulate each other’s aggregation and why combining techniques is essential.
Author

BioGenies Lab

Published

May 21, 2025

Keywords

amyloids, protein aggregation, cross-seeding, cross-interactions, protein misfolding, neurodegeneration, experimental methods, bioinformatics

📌 Project highlights

🎉 New paper out! This time, we dive into something fundamental (and tricky):

👉 how amyloids influence each other’s aggregation 😄

👉 Experimental methods for studying amyloid cross‐interactions

🎧 Audio summary

Amyloid aggregation + cross-seeding + 10 experimental techniques?
Yeah… this one can get dense 😄

👉 So we added a short audio walkthrough 🎧 to make it easier.

🔬 What is this about?

Amyloids are misfolded protein aggregates associated with many diseases:

  • Alzheimer’s 🧠
  • Parkinson’s ⚡
  • systemic amyloidoses

But here’s the twist: 👉 amyloids don’t act alone

They can interact with each other, influencing aggregation in complex ways - a process known as:

🧩 Amyloid cross-interactions

These interactions can:

  • accelerate aggregation
  • inhibit fibril formation
  • create new fibril structures (polymorphs)

🚨 Why this matters

Cross-interactions are central to:

  • 🧠 prion-like propagation
  • 🧬 co-morbidity between diseases
  • ⚡ unexpected aggregation pathways

👉 In short: one protein can change the fate of another

🧠 The core problem

Studying these interactions is extremely difficult because:

  • aggregation is dynamic
  • structures are heterogeneous
  • multiple species coexist (monomers, oligomers, fibrils)

👉 And most importantly: ❌ no single experimental method can capture the full picture

⚙️ Experimental toolbox

The paper provides a complete overview of methods used to study amyloid cross-interactions:

🌟 Fluorescence-based assays

  • Thioflavin T (ThT)
  • Congo Red

👉 Great for:

  • tracking aggregation kinetics

👉 Limitation:

  • indirect, can be misleading alone

🔬 High-resolution imaging

  • Atomic Force Microscopy (AFM)
  • Cryo-EM

👉 Reveals:

  • fibril morphology
  • structural differences

🧪 Spectroscopy & structural methods

  • Solid-state NMR
  • Mass spectrometry

👉 Provides:

  • molecular-level insights
  • composition of heterotypic fibrils

🧫 Immuno-based techniques

  • Immuno-EM

👉 Confirms:

  • presence of mixed (cross-seeded) fibrils

🔗 The key takeaway

👉 You need a combination of methods

A typical robust workflow includes:

  • fluorescence → detect aggregation
  • microscopy → observe morphology
  • structural methods → confirm composition

👉 Only this hybrid approach can capture the full complexity

🧬 Key biological insights

  • 🧩 Cross-seeding is context-dependent
  • ⚡ Same proteins can:
    • accelerate
    • inhibit
    • or reshape aggregation
  • 🧠 Amyloid fibrils are structurally polymorphic
  • 🔄 Interactions can generate new aggregate species

👉 Translation: aggregation is not a single pathway - it’s a network

🚀 Why this matters (big picture)

This review helps:

  • 🧠 design better experiments
  • 🔬 interpret conflicting results
  • ⚙️ improve models of aggregation
  • 💊 guide therapeutic strategies

👉 Especially important for:

  • multi-protein diseases
  • cross-talk between aggregation pathways